Helge Rask-Andersen, head of the inner ear research laboratory at the University of Uppsala in Sweden, has many achievements to his name. He was made an Honorary Member of ENT UK earlier this year. Gerry O’Donoghue caught up with him...
Recent years have seen advances in hearing loss therapeutics, with novel treatments trialled in humans, and others nearing promising first-in-kind clinical trials. First successful clinical trials for a specific form of genetic hearing loss Very exciting news has emerged in...
The true impact of mentoring goes beyond what an audiologist learns to do; it shapes how they think, the confidence with which they practise and the clinician they ultimately become. Knowledge is only the beginning When one thinks about becoming...
Can you start by telling me something about your own background? After my first degree in Psychology at Reading and a year doing other things, I went to Southampton to do the MSc in 1982. My first job after that...
For decades, Professor Tavartkiladze has been the personification of Russian audiology and its best known ambassador on the international stage. Hailing from the republic of Georgia, he has led countless seminal initiatives within Russia to advance the science and practice...
The relatively recent emergence of cochlear implantation as a potential means of restoring hearing to a deafened ear, in the presence of normal hearing in the other ear, has proved an exciting and yet surprising development. James Tysome explores the...
The creator of ENT Expert Opinion, Dr Niall Jefferson, was in the midst of his surgical training in Ear, Nose and Throat Surgery in Australia in 2012. In contemplating his upcoming Fellowship exams, he began to seek out resources that...
So, they are great for screening, but how can otoacoustic emissions be integrated into the diagnostic test battery? Beth Prieve examines the role of diagnostic OAEs by asking three simple questions. Audiologists and otolaryngologists are familiar with otoacoustic emissions (OAEs)...
Human papillomavirus (HPV) is a known aetiological factor in oropharyngeal squamous cell carcinoma (OPSCC). HPV-positive OPSCC is recognised to have a more favourable prognosis than HPV-negative disease. Treatment deintensification for HPV+ OPSCC has therefore been an area of research focus...
Surgery of the Thyroid and Parathyroid Glands - Third Edition is an excellent text for trainee and specialist surgeons with an interest in head and neck endocrine surgery. The organisation of the book simply makes sense, showing progression from the...
Precision medicine (PM) with its ‘four Ps’ (personalised, predictive, preventive and participatory) is about appreciating differences between individuals when offering management options for health problems. Multiple groups interested in rhinology such as EPOS and ARIA supported a review of the...
This small study of 19 pregnant patients, who were diagnosed with papillary thyroid cancer before or during the early stages of pregnancy (up to 20 weeks), assessed the changes of thyroid tumours during pregnancy. Conducted at a single centre over...